207 related articles for article (PubMed ID: 9085149)
1. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions.
Prieto VG; McNutt NS; Lugo J; Reed JA
J Cutan Pathol; 1997 Mar; 24(3):145-50. PubMed ID: 9085149
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi.
Prieto VG; McNutt NS; Lugo J; Reed JA
Am J Surg Pathol; 1997 Dec; 21(12):1450-4. PubMed ID: 9414188
[TBL] [Abstract][Full Text] [Related]
3. Expression of the intermediate filament peripherin in skin tumors.
Kanitakis J; Bourchany D; Faure M; Claudy A
Eur J Dermatol; 1998; 8(5):339-42. PubMed ID: 9683874
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
5. Neurotized nevi of the oral mucosa: an immunohistochemical and ultrastructural analysis of nevic corpuscles.
Ide F; Mishima K; Yamada H; Saito I; Tanaka A; Kusama K
J Oral Pathol Med; 2007 Sep; 36(8):505-10. PubMed ID: 17686011
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions.
Böni R; Wellmann A; Man YG; Hofbauer G; Brinkmann U
Am J Dermatopathol; 1999 Apr; 21(2):125-8. PubMed ID: 10218671
[TBL] [Abstract][Full Text] [Related]
7. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.
Khare VK; Albino AP; Reed JA
J Cutan Pathol; 1998 Jan; 25(1):2-10. PubMed ID: 9508337
[TBL] [Abstract][Full Text] [Related]
8. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
9. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus.
Wong TY; Suster S; Duncan LM; Mihm MC
Hum Pathol; 1995 Feb; 26(2):171-9. PubMed ID: 7860047
[TBL] [Abstract][Full Text] [Related]
10. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
11. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
12. Topography of Protein Kinase C βII in Benign and Malignant Melanocytic Lesions.
Krasagakis K; Tsentelierou E; Chlouverakis G; Stathopoulos EN
Int J Surg Pathol; 2017 Sep; 25(6):497-501. PubMed ID: 28436290
[TBL] [Abstract][Full Text] [Related]
13. [Epithelioid and hyperpigmented melanocytic tumors. An overview].
Kutzner H; Schärer L; Requena L
Pathologe; 2007 Nov; 28(6):411-21. PubMed ID: 17899087
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
King R; Googe PB; Page RN; Mihm MC
Mod Pathol; 2005 Aug; 18(8):1043-7. PubMed ID: 15803191
[TBL] [Abstract][Full Text] [Related]
15. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.
Sparrow LE; Eldon MJ; English DR; Heenan PJ
Am J Dermatopathol; 1998 Jun; 20(3):255-61. PubMed ID: 9650698
[TBL] [Abstract][Full Text] [Related]
16. Acral melanocytic neoplasms: a histologic analysis of 158 lesions.
Boyd AS; Rapini RP
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):740-5. PubMed ID: 7929919
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
Isabel Zhu Y; Fitzpatrick JE
J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
[TBL] [Abstract][Full Text] [Related]
18. Meyerson Phenomenon as a Component of Melanoma in situ.
Sezer E; Özturk Durmaz E; Çetin E; Şahin S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
[TBL] [Abstract][Full Text] [Related]
19. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
20. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression.
Reed JA; McNutt NS; Bogdany JK; Albino AP
J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
